.Net Capital San Diego Venture Capital 
InfoChachkie
AUGUST 29, 2011
Partners at large venture firms generally believe that Orange County is the ideal geography for medical devices, San Diego for telecom and life sciences (along with Boston) and Silicon Valley for everything else. Thanks Mr. Big Firm VC. Despite the fact that we never moved, both companies were successful.
socalTECH
OCTOBER 15, 2020
San Diego-based AlphaTrAI , a fintech startup which is backed by venture capital investor Analytics Ventures, says it is launching its own, extrenal fund, and is expanding its leadership team. the founder of Hightree Advisors, to its advisory board.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Both Sides of the Table
DECEMBER 16, 2014
We’ve been dying to tell you all for a while that we had raised a new venture capital fund and of course given SEC filing requirements the story was somewhat already scooped by the always-in-the-know Dan Primack a few weeks ago. If you want to understand how the VC industry is changing there is a great primer in the link.
socalTECH
SEPTEMBER 24, 2021
San Diego-based biotech Kintara says it is raising $15.0M in a common stock and warrant offering from unmaned "healthcare-focused institutional investors". The company--which is novel cancer therapies for patients who are failing, or are resistant to, current treatment regimens--currently trades on the Nasdaq as KTRA. Wainwright & Co.
socalTECH
NOVEMBER 18, 2014
San Diego-based Renova Therapeutics , a biopharmaceuticals company developing treatments for congestive heart failure and other diseases, has raised $7.52M in a Series C funding round. The company said the funding primarily came from high net worth individuals. As part of the funding, Daniel M. READ MORE>>.
socalTECH
OCTOBER 21, 2013
San Diego-based Arcturus Therapeutics , a developer of RNAi technology, said it has raised $5M in a Series A funding round. According to Arcturus, the funding came from multiple private capital,, high net worth investors from Canada, Japan, and the United States. Names of those capital sources were not announced.
socalTECH
JUNE 3, 2013
San Diego-based Arcturus Therapeutics , which is developing RNAi therapeutics to treat disease, said this morning that it has raised $1.3M The company said the round came from multiple, high net-worth private investors from the U.S. arcturus therapeutics venture capital rnai lifescience biotech' and Canada.
Expert insights. Personalized for you.
233 
Let's personalize your content